Related Experiment Video
Updated: Aug 10, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice
C Antonopoulos1, M Cumberbatch, R J Dearman
1Center for Dermatology, Department of Medicine, University College London, London, United Kingdom.
Insights
Caspase-1 deficiency impairs Langerhans cell (LC) migration, a key step in skin immunity. Inhibiting caspase-1 blocks LC migration and contact hypersensitivity, suggesting it as a therapeutic target.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Langerhans cell (LC) migration is crucial for initiating skin immune responses.
- Tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) are known regulators of LC migration.
- The role of caspase-1 in processing IL-1 alpha and its impact on LC migration remained unclear.
Purpose of the Study:
- To investigate the role of caspase-1 in regulating Langerhans cell migration from the epidermis to draining lymph nodes.
- To determine if caspase-1 activity is essential for TNF-alpha-induced LC migration.
- To assess the functional consequences of impaired LC migration on contact hypersensitivity.
Main Methods:
- Utilized wild-type (WT) and caspase-1-deficient mice.
- Applied contact allergens (2,4-dinitrofluorobenzine, oxazolone) to induce LC migration.
- Administered TNF-alpha and IL-1 beta intradermally to assess their effects on LC migration.
- Used caspase-1 inhibitor (Ac-YVAD-cmk) in vitro (organ culture) and in vivo.
Main Results:
- Caspase-1-deficient mice showed a lack of epidermal LC reduction upon allergen exposure.
- TNF-alpha failed to induce LC migration in caspase-1-deficient mice, unlike in WT mice.
- Contact hypersensitivity responses were significantly inhibited in caspase-1-deficient mice.
- Caspase-1 inhibition blocked LC migration in vitro and in vivo, reducing contact hypersensitivity.
Conclusions:
- Caspase-1 plays a critical role in regulating epidermal Langerhans cell migration.
- Caspase-1 activity is necessary for TNF-alpha-mediated LC migration.
- Targeting caspase-1 with inhibitors presents a potential therapeutic strategy for modulating skin immune responses.
Abstract:
Langerhans cell (LC) migration from epidermis to draining lymph node is a critical first step in cutaneous immune responses. Both TNF-alpha and IL-1 beta are important signals governing this process, but the potential regulatory role of IL-1 alpha processing by caspase-1 is unknown. In wild-type (WT) mice, application of the contact allergens 2,4-dinitrofluorobenzine and oxazolone lead to a marked reduction in epidermal LC numbers, but in caspase-1-deficient mice this reduction was not observed. Moreover, although intradermal injection of TNF-alpha (50 ng) induced epidermal LC migration in WT mice, this cytokine failed to induce LC migration in caspase-1-deficient mice. Intradermal IL-1 beta (50 ng) caused a similar reduction in epidermal LC numbers in both WT and caspase-1-deficient mice, indicating that, given an appropriate signal, caspase-1-deficient epidermal LC are capable of migration. Contact hypersensitivity to both 2,4-dinitrofluorobenzine and oxazolone was inhibited in caspase-1-deficient mice, indicating a functional consequence of the LC migration defect. In organ culture the caspase-1 inhibitor Ac-YVAD-cmk, but not control peptide, potently inhibited the epidermal LC migration that occurs in this system, and reduced spontaneous migration of LC was observed in skin derived from caspase-1-deficient mice. Moreover, Ac-YVAD-cmk applied to BALB/c mouse skin before application of contact sensitizers inhibited LC migration and contact hypersensitivity in vivo. Taken together, these data indicate that caspase-1 may play a central role in the regulation of LC migration and suggest that the activity of this enzyme is amenable to control by specific inhibitors both in vivo and in vitro.
Related Concept Videos
Cell Migration
Caspases
The Extrinsic Apoptotic Pathway

